Lisanti Capital Growth, LLC Ocular Therapeutix, Inc Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$9.7 - $14.34 $1.74 Million - $2.58 Million	-179,700 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $202,793 - $289,316	-15,100 Reduced 7.75%	179,700 $2.55 Million
Q1 2021 May 12, 2021	SELL	$15.82 - $22.11 $2.71 Million - $3.79 Million	-171,240 Reduced 46.78%	194,800 $3.2 Million
Q4 2020 Feb 10, 2021	BUY	$7.91 - $22.95 $2.9 Million - $8.4 Million	366,040 New	366,040 $7.58 Million

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.